CNSX:LOVE

Cannara Biotech Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume69,070 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Cannara Biotech (CNSX:LOVE) Vs. THCX, GLH, ACG, HC, BIO, and BBM

Should you be buying LOVE stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Cannara Biotech, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), and Blueberries Medical (BBM).

Cannara Biotech (CNSX:LOVE) and (THCX.V) (CVE:THCX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings.

Analyst Recommendations

This is a breakdown of recent ratings for Cannara Biotech and (THCX.V), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cannara Biotech0000N/A
(THCX.V)0000N/A

Profitability

This table compares Cannara Biotech and (THCX.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cannara BiotechN/AN/AN/A
(THCX.V)N/AN/AN/A

Valuation & Earnings

This table compares Cannara Biotech and (THCX.V)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cannara BiotechN/AN/AN/AN/AN/A
(THCX.V)N/AN/AN/AN/AN/A

Cannara Biotech (CNSX:LOVE) and 31444 (CNSX:GLH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Cannara Biotech and 31444, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cannara Biotech0000N/A
314440000N/A

Profitability

This table compares Cannara Biotech and 31444's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cannara BiotechN/AN/AN/A
31444N/AN/AN/A

Valuation and Earnings

This table compares Cannara Biotech and 31444's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cannara BiotechN/AN/AN/AN/AN/A
31444N/AN/AN/AN/AN/A

Cannara Biotech (CNSX:LOVE) and 438280 (CNSX:ACG) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Earnings & Valuation

This table compares Cannara Biotech and 438280's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cannara BiotechN/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

Profitability

This table compares Cannara Biotech and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cannara BiotechN/AN/AN/A
438280N/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations for Cannara Biotech and 438280, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cannara Biotech0000N/A
4382800000N/A

815446 (CNSX:HC) and Cannara Biotech (CNSX:LOVE) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

Analyst Ratings

This is a summary of recent ratings and target prices for 815446 and Cannara Biotech, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
8154460000N/A
Cannara Biotech0000N/A

Earnings & Valuation

This table compares 815446 and Cannara Biotech's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
815446N/AN/AN/AN/AN/A
Cannara BiotechN/AN/AN/AN/AN/A

Profitability

This table compares 815446 and Cannara Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
815446N/AN/AN/A
Cannara BiotechN/AN/AN/A

Cannara Biotech (CNSX:LOVE) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of recent recommendations for Cannara Biotech and Bio-Rad Laboratories, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cannara Biotech0000N/A
Bio-Rad Laboratories0000N/A

Earnings & Valuation

This table compares Cannara Biotech and Bio-Rad Laboratories' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cannara BiotechN/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

Profitability

This table compares Cannara Biotech and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cannara BiotechN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

Blueberries Medical (CNSX:BBM) and Cannara Biotech (CNSX:LOVE) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Blueberries Medical and Cannara Biotech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Blueberries Medical0000N/A
Cannara Biotech0000N/A

Profitability

This table compares Blueberries Medical and Cannara Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Blueberries MedicalN/AN/AN/A
Cannara BiotechN/AN/AN/A

Valuation & Earnings

This table compares Blueberries Medical and Cannara Biotech's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blueberries MedicalN/AN/AN/AN/AN/A
Cannara BiotechN/AN/AN/AN/AN/A


Cannara Biotech Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.